Insuline,> 90 %( SDS-PAGE), recombinante, exprimé en cellules NSO, poudre lyophilisée

Code: i8529-25ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Analysis Note

The biological activity is measured by its ability to inhibit recombinant human IGF-1 or IGF-II on MCF-7 cells.

Biochem/physiol Actions

en savoir plus

Votre prix
$927.36 25UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Analysis Note

The biological activity is measured by its ability to inhibit recombinant human IGF-1 or IGF-II on MCF-7 cells.

Biochem/physiol Actions

IGFBP-5 (insulin-like growth factor binding protein-5) interacts with IGFs and thereby controls IGF activity. High levels of IGFBP5 are present in systemic sclerosis and idiopathic pulmonary fibrosis conditions. It also plays a crucial role in cancer progression.

IGFBP-5 binds to bone cells and is the predominant insulin-like growth factor binding protein in bone. When IGFBP-5 binds the extracellular matrix, it modulates IGF activity. Mouse, human, and rat IGFBP-5 share 97% homology.

General description

The gene IGFBP-5 (insulin-like growth factor binding protein-5) is mapped to human chromosome 2q35.

Packaging

25 µg in glass insert

Physical form

Lyophilized from a 0.2 µm filtered solution in 30% acetonitrile and 0.1% TFA.

assay>90% (SDS-PAGE)
biological sourcehuman
formlyophilized powder
Gene Informationhuman ... IGFBP5(3488)
impuritiesendotoxin, tested
mol wt34 kDa by SDS-PAGE (reducing), calculated mol wt ~28 kDa
packagingpkg of 25 µg
potency0.5-1.5 mg per mL ED50
Quality Level100
recombinantexpressed in NSO cells
storage temp.−20°C
UniProt accession no.P24593
Ce produit répond aux critères suivants: